Prognostic value of pre-treatment routine hematological parameters in breast carcinoma: Advantageous or deleterious?. Biomedical Research and Therapy, [S. l.], v. 7, n. 8, p. 3916–3920, 2020. DOI: 10.15419/bmrat.v7i8.621. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/621.. Acesso em: 15 nov. 2024.